双鹭药业(002038.SZ)：目前开发的创新药有长效促卵泡激素、DT-678等

Core Viewpoint - The company, Shuanglu Pharmaceutical, has a diverse product portfolio that includes not only Oseltamivir but also Clindamycin and various immune enhancers such as Thymosin Alpha-1 and Interleukin-2, along with innovative drugs currently under development like Long-acting Follicle Stimulating Hormone and DT-678 [1] Product Portfolio - The company offers a range of products including Oseltamivir and Clindamycin [1] - Immune enhancers in the company's portfolio include Thymosin Alpha-1 and Interleukin-2 [1] Innovative Drug Development - The company is developing innovative drugs such as Long-acting Follicle Stimulating Hormone and DT-678 [1]